±ð°Õ±ð³§¸éâ„¢
Stabilized, feeder-free medium for single-cell passaging of human pluripotent stem cells

Request Pricing
Thank you for your interest in this product. Please provide us with your contact information and your local representative will contact you with a customized quote. Where appropriate, they can also assist you with a(n):
Estimated delivery time for your area
Product sample or exclusive offer
In-lab demonstration
Overview
Specifically developed for single-cell applications, which typically involve shorter passaging schedules at high density, ±ð°Õ±ð³§¸éâ„¢ can be used for routine maintenance, gene editing, or cloning workflows. Use ±ð°Õ±ð³§¸éâ„¢ to produce high-quality hPSCs with improved genetic stability for these applications; stabilization of the components (e.g. FGF2), optimized metabolites, and improved buffering capacity address the increased metabolic demand and cell stress associated with single-cell passaging. Expect equivalent high performance when using ±ð°Õ±ð³§¸éâ„¢ with either daily or restricted feeding schedules.
±ð°Õ±ð³§¸éâ„¢ is compatible with a variety of cell culture matrices, including Corning® Matrigel® hESC-Qualified Matrix (Corning Catalog #354277) and CellAdhereâ„¢ Laminin-521 (Catalog #200-0117).
Each lot of ±ð°Õ±ð³§¸éâ„¢ 10X Supplement is quality-tested in a culture assay using hPSCs.
Data Figures

Figure 1. ±ð°Õ±ð³§¸éâ„¢ Reduces the Occurrence of Genetic Abnormalities in hPSC Cultures Maintained Long-Term Using Single-Cell Passaging, and Lowers the Prevalence of Chromosome 20 Gains
A total of 271 individual clonal sublines derived from 3 hPSC lines (H1, H9, and SCTi003-A) were passaged as single cells using an automated system (Hamilton STARlet Liquid Handling System) for 20 weeks in four test media conditions: two control media (Control Medium A, n = 68; Control Medium B, n = 68) supplemented with 10 µM Y-27632 and ±ð°Õ±ð³§¸éâ„¢ supplemented with either 10 µM Y-27632 (n = 69) or °ä±ô´Ç²Ô±ð¸éâ„¢2 (n = 66). Baseline and 20 week genetic characterization was conducted using single nucleotide polymorphism array (SNPa) profiling. (A) Circle plots show the percentage of subclonal lines that were genetically abnormal after 20 weeks of single-cell passaging. A large number of subclones maintained in Control Medium A (52 of 68; 77%) and B (41 of 68; 60%) were found to be abnormal. The number of abnormal subclones was significantly reduced when maintained in ±ð°Õ±ð³§¸éâ„¢, with only 23 of 69 (33%) acquiring an abnormality. The use of °ä±ô´Ç²Ô±ð¸éâ„¢2 in combination with ±ð°Õ±ð³§¸éâ„¢ showed further improvement with only 11 of 66 (17%) subclones being abnormal. Symbols a - e denote paired conditions compared using Fisher’s Exact Test; p values: a,b,d < 0.001; c, < 0.01; e, < 0.05. (B) Gains involving chromosome 20 were the most recurrent abnormalities, accounting for 79 of the 157 (52%) identified genetic aberrations. The vast majority of chromosome 20 gains were observed in subclones maintained in Control Medium A (41) or B (34) compared to those maintained in ±ð°Õ±ð³§¸éâ„¢ supplemented with Y-27632 (4). No chromosome 20 gains were observed in subclones maintained in ±ð°Õ±ð³§¸éâ„¢ supplemented with °ä±ô´Ç²Ô±ð¸éâ„¢2, a significant finding due to the prevalence of chromosome 20 gains reported in the literature. For additional details about the study methods and results, refer to this .

Figure 2. The Decreased Incidence of Culture-Acquired Genetic Abnormalities in eTeSR Is Characterized by a Lack of Small Copy Number Variants, Particularly in 20q11
These data were generated from the same study described in Figure 1.
(A) Bar graph displays the number of genetic abnormalities defined as small copy number variants (CNVs; < 10,000 kb in length; red bars) and other abnormalities (> 10,000 kb; gray bars) detected in each medium condition. Of the 157 genetic abnormalities detected in this study, 100 (64%) were small CNVs. These were almost exclusively observed in either Control Medium A or B, which, combined, accounted for 94 of the 100 small CNVs detected.
(B) Scatter dot plots show the lengths of all genetic abnormalities detected using SNPa across all medium conditions. Lines represent the median of data points within a condition. Blue dots represent small CNVs (< 10,000 kb in length) detected in chromosome 20q11, while gray dots represent other genetic abnormalities. Gain of chromosome 20q11 was one of the most common CNVs, accounting for 69 of the 100 (69%) small CNVs detected in the study. The small chromosome 20q11 CNV was not present in ±ð°Õ±ð³§¸éâ„¢-maintained subclones supplemented with either Y-27632 or °ä±ô´Ç²Ô±ð¸éâ„¢2. Of note, 97 of the 100 small CNVs detected across all four conditions were below 5,000 kb, which falls below the reliable detectable limit of G-band karyotyping. This highlights that many of these abnormalities would not have been easily detected without the use of SNPa. Each condition comprises data from H1, H9, and SCTi003-A hPSC lines. Kruskal-Wallis Test, p = < 0.0001 (****). For additional details about the study methods and results, refer to this .

Figure 3. hPSCs Cultured As Single Cells in ±ð°Õ±ð³§¸éâ„¢ Exhibit Improved Cell Expansion and Attachment
(A) Representative culture morphology of undifferentiated human ES (H9) and iPS cell lines (SCTi003-A and WLS-1C) maintained in ±ð°Õ±ð³§¸éâ„¢ using single-cell passaging on Corning® Matrigel®-coated plates. hPSCs maintained in ±ð°Õ±ð³§¸éâ„¢ display a homogeneous morphology that is consistent between hPSC lines.
(B) Four hPSC lines were single-cell passaged in either mTeSRâ„¢1, mTeSRâ„¢ Plus, or ±ð°Õ±ð³§¸éâ„¢ on Corning® Matrigel®-coated plates using TrypLEâ„¢ Express for 11 passages. Cultures were maintained using a 4-5-5 day passaging schedule (see manual) using a restricted feeding schedule for mTeSRâ„¢ Plus and ±ð°Õ±ð³§¸éâ„¢, and daily feeding for mTeSRâ„¢1. ±ð°Õ±ð³§¸éâ„¢-maintained cultures show improved expansion rates compared to mTeSRâ„¢1 and mTeSRâ„¢ Plus when using single-cell passaging.
(C) Representative whole-well images of the STiPS-R038 hPSC line 24 hours post-plating stained with Hoechst 33342. hPSCs were seeded at 15,000 cells/well in either mTeSRâ„¢1, mTeSRâ„¢ Plus, or ±ð°Õ±ð³§¸éâ„¢ supplemented with 10 μM Y-27632 on Matrigel®-coated 96-well plates. Plates were fixed, stained for Hoechst 33342, and imaged using the IXM Micro (Molecular Devices).

Figure 4. ±ð°Õ±ð³§¸éâ„¢ Supports Efficient Gene-Editing in hPSCs
Using the ArciTectâ„¢ CRISPR-Cas9 system, GFP-labeled hPSC lines (H1 and WLS-1C) were electroporated in the presence of a ribonucleic protein (RNP) complex consisting of Cas9 and a guide RNA targeting the GFP sequence. A donor template was also included encoding a two base pair change, resulting in the conversion of the GFP sequence to a BFP sequence, which can be determined using flow cytometry. Data points in the graph represent the gene-editing outcomes of three independent experiments. Both knock-out (A) and knock-in (B) conditions show effective gene-editing with ±ð°Õ±ð³§¸éâ„¢-maintained cultures, displaying a higher knock-in efficiency compared to mTeSRâ„¢ Plus-maintained cultures. The mock condition shows ±ð°Õ±ð³§¸éâ„¢-maintained cells that have been incubated with the RNP complex and donor template but have not been electroporated. Error bars represent standard deviation of replicates.

Figure 5. High Cloning Efficiencies Are Achieved Following Single-Cell Deposition Using ±ð°Õ±ð³§¸éâ„¢ Supplemented with °ä±ô´Ç²Ô±ð¸éâ„¢2
(A) Four hPSC lines were seeded at 1 cell/well using single-cell deposition in ±ð°Õ±ð³§¸éâ„¢ supplemented with °ä±ô´Ç²Ô±ð¸éâ„¢2 on Vitronectin-XFâ„¢-coated 96-well plates. Each data point represents one 96-well plate over three independent experiments. The average cloning efficiency across all four cell lines in ±ð°Õ±ð³§¸éâ„¢ was 51 ± 3%.
(B) Representative 96-well plate imaged at Day 8 post-plating, showing colonies generated in ±ð°Õ±ð³§¸éâ„¢ using single-cell deposition. Orange circles highlight wells with a colony present.

Figure 6. hPSCs Maintained in ±ð°Õ±ð³§¸éâ„¢ Express Markers of the Undifferentiated State and Differentiate Efficiently to Three Germ Layers
(A) hPSCs maintained in ±ð°Õ±ð³§¸éâ„¢ express markers of the undifferentiated state with > 98% of cells staining positive for OCT4 and TRA-1-60, as determined by flow cytometry at passage 12 and 20. Data points represent the percent positive at each time point with bars representing the average over the two time points for each cell line (n = 4 cell lines).
(B) Four hPSC lines were maintained in ±ð°Õ±ð³§¸éâ„¢ for at least 7 passages before being differentiated toward the three germ layers using the STEMdiffâ„¢ SMADi Neural Induction Kit, STEMdiffâ„¢ Mesoderm Induction Medium, and STEMdiffâ„¢ Definitive Endoderm Kit. All hPSC lines demonstrated efficient differentiation to all three lineages. Error bars represent the mean and standard deviation of three technical replicates.

Figure 7. Global Gene Expression Profiles Are Comparable Between ±ð°Õ±ð³§¸éâ„¢ Single-Cell Passaged Cultures and mTeSRâ„¢ Plus Aggregate Passaged Cultures
Whole transcriptome analysis was performed using the Illumina NextSeq 500 on three hPSC lines passaged as either aggregates in mTeSRâ„¢ Plus or as single cells in ±ð°Õ±ð³§¸éâ„¢. (A) PCA analysis shows that samples cluster by cell line with minimal effect from cell culture medium and passaging technique. (B) A heat map of global gene expression showing comparable gene expression between conditions. No gene ontology or signaling pathway enrichment was detected (n = 3 hPSC lines).

Figure 8. hPSCs Maintained in ±ð°Õ±ð³§¸éâ„¢ Can Be Differentiated to Cerebral Organoids with the STEMdiffâ„¢ Cerebral Organoid Kit
(A) H9 and SCTi003-A cells maintained in ±ð°Õ±ð³§¸éâ„¢ or mTeSRâ„¢ Plus were differentiated to cerebral organoids using the STEMdiffâ„¢ Cerebral Organoid Kit (Catalog #08570). RT-qPCR analysis showed that PAX6, MAP2 and TTR gene expression were similar between ±ð°Õ±ð³§¸éâ„¢ and mTeSRâ„¢ Plus. Each point represents an individual organoid sample and bars represent mean ± standard error.
(B) Day 60 cerebral organoids from SCTi003-A cells were stained for CTIP2 (green), and PAX6 (magenta), MAP2 (blue). Cortical regions are defined by PAX6 positive progenitor cells. These progenitors give rise to cortical plate neurons indicated by CTIP2 and MAP2 expression. Scale bar: 500 µm. Magnification 100X.

Figure 9. hPSCs Maintained in ±ð°Õ±ð³§¸éâ„¢ Differentiate to Forebrain-Type Neurons Using the STEMdiffâ„¢ Forebrain Neuron Differentiation Kit with Monolayer Protocol
SCTi003-A (data shown) and STiPS-M001 (data not included) cells maintained in ±ð°Õ±ð³§¸éâ„¢ or mTeSRâ„¢ Plus were differentiated to forebrain neurons using the STEMdiffâ„¢ Forebrain Neuron Differentiation Kit (Catalog #08600). At Day 14 of maturation, neuronal morphology was observed (top panels; scale bar 200 µm). The resulting cultures (bottom panels; scale bar: 500 µm) contained populations of TuJ1 (class III β-tubulin; red) positive neurons. Nuclei are labeled with DAPI (blue).

Figure 10. hPSCs Maintained in ±ð°Õ±ð³§¸éâ„¢ Can Be Differentiated to Midbrain Neurons Using the STEMdiffâ„¢ Midbrain Neuron Differentiation Kit with Monolayer Protocol
SCTi003-A (data shown) and STiPS-M001 (data not included) cells maintained in ±ð°Õ±ð³§¸éâ„¢ or mTeSRâ„¢ Plus were differentiated to midbrain neurons using the STEMdiffâ„¢ Midbrain Neuron Differentiation Kit (Catalog #100-0038). At Day 14 of maturation, neuronal morphology was observed (top panels; scale bar 200 µm). The resulting cultures (bottom panels; scale bar: 500 µm) contained populations of TuJ1 (class III β-tubulin; red) positive neurons that express the dopaminergic marker Tyrosine Hydroxylase (TH; green). Nuclei are labeled with DAPI (blue).

Figure 11. hPSCs Maintained in ±ð°Õ±ð³§¸éâ„¢ Can Be Differentiated to Intestinal Organoids Using the STEMdiffâ„¢ Intestinal Organoid Kit
(A) H9 cells maintained in ±ð°Õ±ð³§¸éâ„¢ progress through the three-stage differentiation process to generate human intestinal organoids using the STEMdiffâ„¢ Intestinal Organoid Kit (Catalog #05140). At Day 8, following mid-/hindgut induction, efficient spheroid formation is observed. Collected spheroids, embedded in the extracellular matrix, can be maintained and expanded for several passages (P0-P2). Scale: 1 mm.
(B) At Day 13 (P2), organoids from H9 and SCTi003-A cells expressed markers of the intestinal epithelium EPCAM, cell proliferation marker Ki67, and KRT20 for more differentiated epithelial cell types. Expression of markers associated with epithelial cells (β-catenin), enteroendocrine cells (CHGA), small intestine lining (SI), and goblet cells (MUC2) were also observed in these organoids. Scale bar: 100 µm.
(C) RT-qPCR analysis showed similar gene expression for CDX2, ALPi (intestinal Alkaline Phosphatase), MUC2, and CHGA markers between the intestinal organoid generated from the ±ð°Õ±ð³§¸éâ„¢- and mTeSRâ„¢ Plus-maintained hPSCs. Data are reported as mean ± standard deviation and each point represents a technical replicate. for the three technical replicates.

Figure 12. hPSCs Maintained in ±ð°Õ±ð³§¸éâ„¢ Can Be Differentiated to Hepatocyte-Like Cells Efficiently Using the STEMdiffâ„¢ Hepatocyte Kit
(A) WLS-1C and SCTi003-A cells, maintained in ±ð°Õ±ð³§¸éâ„¢ or mTeSRâ„¢ Plus, were differentiated to hepatocyte-like cells (HLCs) using the STEMdiffâ„¢ Hepatocyte Kit (Catalog #100-0520) and analyzed by flow cytometry on Day 21 for expression of mature hepatocyte markers, ALB and A1AT. Percentages and total number of cells expressing ALB and A1AT following differentiation are shown, with data expressed as mean ± standard error. At Day 21, 70% of HLCs derived from ±ð°Õ±ð³§¸éâ„¢-maintained hPSCs were ALB+/A1AT+.
(B) Day 21 HLCs derived from SCTi003-A were fixed with 4% paraformaldehyde and permeabilized before being stained with mature hepatocyte marker ALB (green), epithelial marker EPCAM (red), and DAPI (blue). Characteristic polygonal hepatocyte-like morphology and binucleation are observed in both conditions.

Figure 13. hPSCs Maintained in ±ð°Õ±ð³§¸éâ„¢ Can Be Differentiated to Ventricular Cardiomyocytes Efficiently and Robustly Using the STEMdiffâ„¢ Ventricular Cardiomyocyte Differentiation Kit
(A) SCTi003-A, H9 and WLS-1C cells maintained in ±ð°Õ±ð³§¸éâ„¢ were differentiated to ventricular cardiomyocytes using the STEMdiffâ„¢ Ventricular Cardiomyocyte Differentiation Kit (Catalog #05010). By Day 16, cells from all three lines were differentiated to ventricular cardiomyocytes, as shown in the phase images (Scale bar 500 µm).
(B) Ventricular cardiomyocytes from SCTi003-A cells were stained for cTnT markers (Red) and DAPI (left panel; scale bar: 25 µm). Flow cytometry analysis (right panel) showed that cell populations positive for cTnT were observed in all three hPSC lines. Data are expressed as mean ± standard deviation.
(C) Cardiomyocytes, derived from SCTi003-A cells maintained in eTeSR, display the characteristic electrical microelectrode array (MEA) electrical profile of ventricular cardiomyocytes. Stable beat rate is observed with a large depolarization spike followed by a smaller repolarization deflection.
Protocols and Documentation
Find supporting information and directions for use in the Product Information Sheet or explore additional protocols below.
Applications
This product is designed for use in the following research area(s) as part of the highlighted workflow stage(s). Explore these workflows to learn more about the other products we offer to support each research area.
Resources and Publications
Educational Materials (12)
Related Products
- ´¡°ä°ä±«°Õ´¡³§·¡â„¢
Cell detachment solution
- °ä±ô´Ç²Ô±ð¸éâ„¢2
Defined supplement for improving survival of human ES and iPS cells in single-cell workflows
- Healthy Control Human iPSC Line, Female, SCTi...
Human pluripotent stem cell line, frozen
- CellAdhereâ„¢ Laminin-521
Matrix for maintenance of human ES and iPS cells in combination with TeSRâ„¢ maintenance media
Item added to your cart
±ð°Õ±ð³§¸éâ„¢
This product was developed under license to intellectual property owned by WiCellâ„¢ Research Institute. This product is sold for research use only (whether the buyer is an academic or for-profit entity) under a non-transferable, limited-use license. Purchase of this product does not include the right to sell, use or otherwise transfer this product for commercial purposes (i.e., any activity undertaken for consideration, such as use of this product for manufacturing, or resale of this product or any materials made using this product, or use of this product or any materials made using this product to provide services) or clinical use (i.e., administration of this product or any material using this product to humans) or the right to implant any material made using this product into an animal by, or in collaboration with, a for-profit entity, for purposes other than basic pre-clinical research applications (including without limitation teratoma assays) to validate the function of the cells.
PRODUCTS ARE FOR RESEARCH USE ONLY AND NOT INTENDED FOR HUMAN OR ANIMAL DIAGNOSTIC OR THERAPEUTIC USES UNLESS OTHERWISE STATED. FOR ADDITIONAL INFORMATION ON QUALITY AT º£½ÇÆÆ½â°æ, REFER TO WW.º£½ÇÆÆ½â°æ.COM/COMPLIANCE.